期刊
NATURE CLINICAL PRACTICE RHEUMATOLOGY
卷 4, 期 12, 页码 657-666出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncprheum0950
关键词
autoimmunity; B cells; interleukin 10; regulatory T cells; Toll-like receptor
资金
- Medical Research Council [G117/515] Funding Source: researchfish
- Medical Research Council [G117/515] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
- MRC [G117/515] Funding Source: UKRI
B lymphocytes contribute to immunity through organogenesis of secondary lymphoid organs, presentation of antigen to T cells, production of antibodies, and secretion of cytokines. Their roles in autoimmune diseases are complex. Clinical trials have shown that depleting B cells can significantly ameliorate such diseases, underlining the contributions of B cells to pathogenesis. Conversely, B-cell depletion can lead to exacerbation of symptoms in some patients. In mice, B cells can offer protection from chronic autoimmune pathologies. It is important to understand the mechanisms responsible for the distinct roles of B cells in autoimmune diseases, and investigation of these processes could highlight new therapeutic strategies. Here, we review recent progress in our understanding of the suppressive functions of activated B cells in mice, as well as the promising potential of B cells for use as cell-based therapy for experimental autoimmune diseases, and, finally, discuss the possibility of translating this cellular approach to treat human autoimmune diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据